Atsushi Isoda

562 total citations
27 papers, 321 citations indexed

About

Atsushi Isoda is a scholar working on Oncology, Hematology and Pathology and Forensic Medicine. According to data from OpenAlex, Atsushi Isoda has authored 27 papers receiving a total of 321 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 14 papers in Hematology and 10 papers in Pathology and Forensic Medicine. Recurrent topics in Atsushi Isoda's work include Multiple Myeloma Research and Treatments (11 papers), Lymphoma Diagnosis and Treatment (8 papers) and Peptidase Inhibition and Analysis (6 papers). Atsushi Isoda is often cited by papers focused on Multiple Myeloma Research and Treatments (11 papers), Lymphoma Diagnosis and Treatment (8 papers) and Peptidase Inhibition and Analysis (6 papers). Atsushi Isoda collaborates with scholars based in Japan and Nigeria. Atsushi Isoda's co-authors include Morio Sawamura, Morio Matsumoto, Yuri Miyazawa, Morio Matsumoto, Akio Saito, Kyoichi Kaira, Tomohiro Kinoshita, Mitsune Tanimoto, Kazuhito Yamamoto and Taro Masunari and has published in prestigious journals such as Blood, British Journal of Haematology and Cancer Science.

In The Last Decade

Atsushi Isoda

25 papers receiving 316 citations

Peers

Countries citing papers authored by Atsushi Isoda

Since Specialization

Citations

This map shows the geographic impact of Atsushi Isoda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Atsushi Isoda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Atsushi Isoda more than expected).

Fields of papers citing papers by Atsushi Isoda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Atsushi Isoda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Atsushi Isoda. The network helps show where Atsushi Isoda may publish in the future.

Co-authorship network of co-authors of Atsushi Isoda

This figure shows the co-authorship network connecting the top 25 collaborators of Atsushi Isoda. A scholar is included among the top collaborators of Atsushi Isoda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Atsushi Isoda. Atsushi Isoda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Improving gastrointestinal quality of life: romidepsin to tucidinostat in a case of angioimmunoblastic T cell lymphoma 2024 ·BMJ Case Reports ·Atsushi Isoda, (unknown), (unknown), Akio Saito	2
2	Coexistence of IgG4-Related Disease and Reactive Granuloma to Paraffin Plombage 2023 ·Cureus ·Atsushi Isoda, (unknown), (unknown), Hirono Iriuchishima, Akio Saito	1
3	Kikuchi-Fujimoto Disease in Human Leukocyte Antigen Partially Matched Siblings: A Case Study of Familial Susceptibility 2023 ·Cureus ·Atsushi Isoda, Kenichi Tahara, Munenori Ide	0
4	Prevalence and clinical outcomes of vitamin D deficiency among Japanese multiple myeloma patients: a single-center observational study 2023 ·Supportive Care in Cancer ·Atsushi Isoda, Yuri Miyazawa, Tetsuya Ishikawa, (unknown), Keita Nakayama, (unknown), Hirono Iriuchishima, Akio Saito, Morio Matsumoto, Morio Sawamura	1
5	Pembrolizumab-induced Pure Red Cell Aplasia Successfully Treated with Intravenous Immunoglobulin 2020 ·Internal Medicine ·Atsushi Isoda, Yuri Miyazawa, Kenichi Tahara, (unknown), Akio Saito, Morio Matsumoto, Morio Sawamura	12
6	Evaluation of the Revised International Staging System (R-ISS) in Japanese patients with multiple myeloma 2019 ·Annals of Hematology ·Shuji Ozaki, Hiroshi Handa, Takayuki Saitoh, Hirokazu Murakami, (unknown), Hideki Asaoku, Kenshi Suzuki, Atsushi Isoda, Morio Matsumoto, Morio Sawamura, Kazutaka Sunami, Naoki Takezako, Shotaro Hagiwara, Yoshiaki Kuroda, Takaaki Chou, E Nagura, Kazuyuki Shimizu	9
7	Bortezomib maintenance therapy in transplant-ineligible myeloma patients who plateaued after bortezomib-based induction therapy: a multicenter phase II clinical trial 2018 ·International Journal of Hematology ·Atsushi Isoda, Kayoko Murayama, Shigeki Ito, (unknown), Masaki Iino, Yuri Miyazawa, Morio Matsumoto, Hiroshi Handa, (unknown), (unknown), (unknown), Kiyoshi Kitano, Yukio Hirabayashi, Hideyuki Nakazawa, Fumihiro Ishida, (unknown), Keita Kirito, Takaaki Chou, Hirokazu Murakami, (unknown)	5
8	Intra-patient dose escalation of panobinostat in patients with relapsed/refractory multiple myeloma 2017 ·Leukemia & lymphoma ·Atsushi Isoda, Tetsuya Ishikawa, Yuri Miyazawa, (unknown), Morio Matsumoto, Morio Sawamura	1
9	Palonosetron, aprepitant, and dexamethasone for prevention of nausea and vomiting after high-dose melphalan in autologous transplantation for multiple myeloma: A phase II study 2016 ·International Journal of Hematology ·Atsushi Isoda, Rie Saito, (unknown), (unknown), (unknown), Tetsuya Ishikawa, Yuri Miyazawa, Morio Matsumoto, Morio Sawamura, (unknown)	11
10	Silent venous thromboembolism in multiple myeloma patients treated with lenalidomide 2015 ·International Journal of Hematology ·Atsushi Isoda, (unknown), Yuri Miyazawa, (unknown), (unknown), (unknown), Morio Sawamura, Morio Matsumoto	4
11	Rituximab monotherapy as a first-line treatment for pulmonary mucosa-associated lymphoid tissue lymphoma 2014 ·International Journal of Hematology ·(unknown), Hisao Imai, Keita Mori, (unknown), Atsushi Isoda, Keichiro Mihara, Morio Matsumoto, Ryusei Saito, Toshiaki Takahashi, Takashi Ikeda	20
12	A new staging system to predict prognosis of patients with multiple myeloma in an era of novel therapeutic agents 2014 ·European Journal Of Haematology ·Hirono Iriuchishima, Takayuki Saitoh, Hiroshi Handa, Atsushi Isoda, Morio Matsumoto, Morio Sawamura, Atsushi Iwasaki, (unknown), (unknown), Yoshiko Sasaki, Takeki Mitsui, Akihiko Yokohama, Norifumi Tsukamoto, Hirokazu Murakami, Yoshihisa Nojima	12
13	Retrospective analysis of prognostic factors for angioimmunoblastic T-cell lymphoma: a multicenter cooperative study in Japan 2012 ·Blood ·Takashi Tokunaga, Kazuyuki Shimada, Kazuhito Yamamoto, Dai Chihara, (unknown), (unknown), Mitsune Tanimoto, (unknown), Atsushi Isoda, Akira Sakai, Hikaru Kobayashi, Kunio Kitamura, Kosei Matsue, Masafumi Taniwaki, (unknown), Yoshio Saburi, Taro Masunari, Tomoki Naoe, Shigeo Nakamura, Tomohiro Kinoshita	92
14	18F-FAMT in patients with multiple myeloma: clinical utility compared to 18F-FDG 2012 ·Annals of Nuclear Medicine ·Atsushi Isoda, Tetsuya Higuchi, Sachiko Nakano, Yukiko Arisaka, Kyoichi Kaira, Tadashi Kamio, Momoko Mawatari, Morio Matsumoto, Morio Sawamura, Yoshito Tsushima	20
15	Reduced risk of bacterial infection in multiple myeloma patients with VAD regimen without intermittent high-dose dexamethasone 2010 ·International Journal of Hematology ·Atsushi Isoda, Morio Matsumoto, Hirotaka Nakahashi, Momoko Mawatari, (unknown), Morio Sawamura	6
16	B-Cell Lymphoma Associated with Sjögren's Syndrome among Japanese Patients : A Clinicopathologic and Immunohistochemical Study of 15 Cases 2009 ·Journal of Clinical and Experimental Hematopathology ·Masaru Kojima, (unknown), Akihiko Yokohama, Yoshiyuki Suzuki, Kazuhiko Shimizu, (unknown), Kayoko Murayama, (unknown), Atsushi Isoda, Ken Shimizu, Hideaki Itoh, Nobuhide Masawa, Katsue Yoshida, Hiroshi Inagaki	14
17	Chronic inflammatory demyelinating polyneuropathy accompanied by chronic myelomonocytic leukemia: possible pathogenesis of autoimmunity in myelodysplastic syndrome 2009 ·International Journal of Hematology ·Atsushi Isoda, Atsushi Sakurai, Yoshiyuki Ogawa, Yuri Miyazawa, Akio Saito, Morio Matsumoto, Morio Sawamura	22
18	Expression of CD55 and CD59 on peripheral blood cells in patients with lymphoproliferative disease of granular lymphocytes 2006 ·International Journal of Laboratory Hematology ·Atsushi Isoda, (unknown), Takeki Mitsui, Arito Yamane, Nahoko Hatsumi, T Matsushima, Hirokazu Murakami, Yusuke Nojima, (unknown)	3
19	TCR Vβ repertoire analysis in CD56⁺ CD16^dim/− T‐cell large granular lymphocyte leukaemia: association with CD4 single and CD4/CD8 double positive phenotypes 2003 ·British Journal of Haematology ·Masamitsu Karasawa, Takeki Mitsui, Atsushi Isoda, (unknown), (unknown), Akihiko Yokohama, Hiroshi Handa, Takafumi Matsushima, Norifumi Tsukamoto, Hirokazu Murakami, Yoshihisa Nojima	8
20	The naive T‐lymphocyte compartment is well preserved in patients with chronic myelogenous leukaemia in chronic phase 2002 ·British Journal of Haematology ·Atsushi Isoda, Akihiko Yokohama, Takafumi Matsushima, Norifumi Tsukamoto, Yoshihisa Nojima, Masamitsu Karasawa	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact